This is a working overview of synthetic peptide, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-13. Anything still debated is marked as such rather than presented as settled.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
==== MeSH D06.472.931 – thyroid hormones ==== MeSH D06.472.931.103 – dextrothyroxine MeSH D06.472.931.208 – diiodotyrosine MeSH D06.472.931.388 – monoiodotyrosine MeSH D06.472.931.669 – thyroid gland, desiccated MeSH D06.472.931.740 – thyronines MeSH D06.472.931.740.180 – diiodothyronines MeSH D06.472.931.740.385 – triiodothyronine MeSH D06.472.931.740.590 – triiodothyronine, reverse MeSH D06.472.931.812 – thyroxine
Izonsteride (developmental code name LY-320,236) is a selective inhibitor of the 5α-reductase, with dual effects on both the type I and type II isoforms of the enzyme. It was under development by Eli Lilly and Company and Fujisawa for the treatment of benign prostatic hyperplasia but was never marketed. Izonsteride may also be useful in the treatment of androgenic alopecia.
Church's Texas Chicken menu features a variety of fried chicken options alongside classic sides and desserts. Their menu also includes chicken tenders and boneless wings. Accompanying these main dishes are classic Southern sides such as mashed potatoes with gravy, fried okra, coleslaw, corn on the cob and jalapeño peppers. Desserts include honey butter biscuits and apple pie. Church's Texas Chicken restaurants offer a seasonal seafood menu, featuring shrimp and crispy fish. Since 1952, Church's Texas Chicken restaurants have served beverages supplied by The Coca-Cola Company. In 2008, the companies reaffirmed their commitment with the renewal of their existing contract, continuing to provide customers with Coca-Cola beverages. In 2021, Church's Chicken appointed Performance Food Group Company as its exclusive distributor in the United States to 2026.
He has appeared on BBC Horizon, UK Channel 5 and the History Channel. He appeared on the 2013 Discovery Channel program "Red Rain". He has an association with Daisaku Ikeda, president of the Buddhist sect Soka Gakkai International, that led to the publication of a dialogue with him, first in Japanese and later in English, on the topic of Space and Eternal Life.
Lucy Letby (born 4 January 1990) is a British former NHS neonatal nurse convicted of murdering seven babies and attempting to murder seven others at the Countess of Chester Hospital in Chester between June 2015 and June 2016. She was investigated after an unusual cluster of deaths in the hospital's neonatal unit. Charged in November 2020 with seven counts of murder and fifteen counts of attempted murder relating to seventeen babies, Letby was prosecuted on the basis of her presence at many of the incidents, two abnormal blood test results and skin discolouration interpreted as signs of insulin poisoning and air embolism, inconsistencies in medical records, her removal of nursing handover sheets from the hospital, and handwritten notes interpreted by the prosecution as a confession. In August 2023, she was found guilty on seven counts each of murder and attempted murder, and acquitted on two counts of attempted murder. The jury was unable to reach verdicts on six further counts. She received fourteen whole life orders, meaning life imprisonment without the possibility of parole. One of the unresolved attempted murder charges was retried in July 2024, resulting in a fifteenth whole life order. The senior management of the Countess of Chester Hospital was criticised for failing to act on clinicians' concerns, prompting the British government to commission an independent inquiry. Cheshire Police examined extra cases, resulting in three arrests related to corporate manslaughter. Two applications for permission to appeal have been refused by the Court of Appeal.
Sources: en.wikipedia.org
In a passage describing the challenges of "boiling an egg", for instance, the reader is not given any clue that the original Japanese text discussed a speciality of Kyoto-style cuisine called koya dofu (高野豆腐), a freeze dried tofu dish named after the Koyasan region from which it originates. In contrast to the symbolism of Kyoto-style cuisine as authentic Japanese fare, Tanizaki disparages Kobe as "foreign" including items like liver sausage from a German butcher. Of Tanazaki's characters, Louise, a prostitute involved with Kaname, is the most strongly associated with Kobe fare. Though Misako's consumption of the Kobe style food is alluded to from time to time, Misako herself is more clearly associated with the eastern Japanese fare of Tokyo.
=== PDF generation === ColdFusion can generate PDF documents using standard HTML (i.e. no additional coding is needed to generate documents for print). CFML authors place HTML and CSS within a pair of cfdocument tags (or new in ColdFusion 11, cfhtmltopdf tags). The generated document can then either be saved to disk or sent to the client's browser. ColdFusion 8 introduced also the cfpdf tag to allow for control over PDF documents including PDF forms, and merging of PDFs. These tags however do not use Adobe's PDF engine but cfdocument uses a combination of the commercial JPedal Java PDF library and the free and open source Java library iText. The library used by cfhtmltopdf since cf11 has been an embedded WebKit IMPLEMENTATION. Since cf2023, Adobe has licensed PDFReactor to be the default engine underlying cfhtmltopdf.
Such activity requires the proteasome to cleave the substrate protein internally, rather than processively degrading it from one terminus. It has been suggested that long loops on these proteins' surfaces serve as the proteasomal substrates and enter the central cavity, while the majority of the protein remains outside. Similar effects have been observed in yeast proteins; this mechanism of selective degradation is known as regulated ubiquitin/proteasome dependent processing (RUP).
Conventions, festivals and large events were permitted, and all businesses, schools, and places of recreation could be fully open. On July 15, 2020, Pritzker announced a new COVID-19 mitigation plan in the event of a resurgence of COVID-19. The metrics that would be used to determine whether COVID-19's spread in a region required additional mitigations were a sustained increase in 7-day rolling average (7 out of 10 days) in the positivity rate; and one of the following: a sustained 7-day increase in hospital admissions for a COVID-19 or the reduction in hospital capacity. Another metric was three consecutive days averaging greater than or equal to 8% positivity rate.
Sources: en.wikipedia.org
==== Impossibility of the "negligence" ==== According to the "Corporate Negligence" argument, workers had been cleaning out pipes with water nearby. This water was diverted due to a combination of improper maintenance, leaking and clogging, and eventually ended up in the MIC storage tank. Indian scientists also suggested that additional water might have been introduced as a "back-flow" from a defectively designed vent-gas scrubber. None of these theoretical routes of entry were ever successfully demonstrated during tests by the Central Bureau of Investigation (CBI) and UCIL engineers. A Union Carbide commissioned analysis conducted by Arthur D. Little claims that the Negligence argument was impossible for several tangible reasons:
The beta sheet (β-sheet, also β-pleated sheet) is a common motif of the regular protein secondary structure. Beta sheets consist of beta strands (β-strands) connected laterally by at least two or three backbone hydrogen bonds, forming a generally twisted, pleated sheet. A β-strand is a stretch of polypeptide chain typically 3 to 10 amino acids long with backbone in an extended conformation. The supramolecular association of β-sheets has been implicated in the formation of the fibrils and protein aggregates observed in amyloidosis, Alzheimer's disease and other proteinopathies.
Mauritania was the last country to abolish slavery (in 1981), and it is estimated that 20% of its population of 3 million people are enslaved as bonded labourers, with black Haratin being slaves and Berbers and Arabs the owners. Slavery in Mauritania was criminalized in August 2007. However, although slavery, as a practice, was legally banned in 1981, it was not a crime to own a slave until 2007. Although many slaves have escaped or have been freed since 2007, as of 2012, only one slave owner had been sentenced to serve time in prison.
== Freedom == Freedom House's Freedom in the World 2019 ranked Thailand "not free". Its 2019 score declined from the previous year. The study scored 195 nations and 14 territories. In ASEAN, Indonesia ranked number one, but was only ranked "partly free". Other ASEAN nations were ranked in this order from top to bottom: "Partly free": Philippines; Malaysia; Singapore; Myanmar. "Not free": Thailand; Brunei; Cambodia; Vietnam; Laos. Freedom House, in its report, Freedom in the World 2018, ranked Thailand as "not free". Of the 210 countries ranked, Thailand was ranked 156 (1=most free; 210=least free). Other ASEAN nations ranked were: Indonesia, 98; Philippines, 105; Singapore, 124; Malaysia, 134; Myanmar, 154; Cambodia, 158; Brunei, 161; Vietnam, 178; Laos, 193. Freedom House, in its Freedom in the World 2015 report, reduced Thailand's previous ranking of "partly free" to "not free", making it one of 51 nations and territories in that category.
=== Australia and New Zealand === The Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) is the professional body that oversees the education and certification of medical physicists in Australia and New Zealand and has a mission to advance services and professional standards in medical physics and biomedical engineering.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.